High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients

Nephrology Dialysis Transplantation

Volumn 29, Issue 2, 2014, Pages 414-422

  Bellien, Jérémy ^a,b,c   Fréguin Bouilland, Caroline ^a,b,c   Joannidès, Robinson ^a,b,c   Hanoy, Mélanie ^a   Rémy Jouet, Isabelle ^b,c   Monteil, Christelle ^c,d   Iacob, Michèle ^a   Martin, Laurent ^b   Renet, Sylvanie ^b,c   Vendeville, Cathy ^c,d   Godin, Michel ^a,b,c   Thuillez, Christian ^a,b,c   Le Roy, Frank ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY OF ROUEN   (France)

^d Envtl   (France)

Author keywords

arterial stiffness; end stage renal disease; endothelium; haemodiafiltration; haemodialysis

Indexed keywords

BETA 2 MICROGLOBULIN; CELL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATE; POLYSULFONE; PROTEIN KINASE C BETA 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREMIC TOXIN;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTINUOUS HEMODIALYSIS; CONTROLLED STUDY; DIASTOLE; DISEASE MARKER; END STAGE RENAL DISEASE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GENE EXPRESSION; HEART SIZE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; MALE; ONLINE HEMODIAFILTRATION; OXIDATIVE STRESS; PARALLEL DESIGN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; UREMIA;

ARTERIAL STIFFNESS; END-STAGE RENAL DISEASE; ENDOTHELIUM; HAEMODIAFILTRATION; HAEMODIALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS; VASODILATION;

EID: 84896715233     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft448     Document Type: Article

References (44)

1. ERA-EDTA Registry Annual Report 2010. Academic Medical Center, Department of Medical Informatics. Amsterdam, The Netherlands
2. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789
3. London GM. Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14: S305-S309
4. Vanholder R, Baurmeister U, Brunet P et al. European Uremic Toxin Work Group. A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008; 19: 863-870
5. Jourde-Chiche N, Dou L, Cerini C et al. Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Semin Dial 2011; 24: 327-337
6. Joannides R, Bakkali EH, Le Roy F et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 1997; 12: 2623-2628
7. Tonelli M, Pannu N, Manns B. Oral phosphate binders in patients with kidney failure. N Engl J Med 2010; 362: 1312-1324
8. Floccari F, Aloisi C, Crascì E et al. Oxidative stress and uremia. Med Res Rev 2005; 25: 473-486
9. Panichi V, Rizza GM, Paoletti S et al. RISCAVID Study Group. Chronic inflammation and mortality in haemodialysis: Effect of different renal replacement therapies. results from the RISCAVID study. Nephrol Dial Transplant 2008; 23: 2337-2343
10. Locatelli F, Martin-Malo A, Hannedouche T et al. Membrane Permeability Outcome (MPO) Study Group. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654
11. Palmer SC, Rabindranath KS, Craig JC et al. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database Syst Rev 2012; 9: CD005016
12. Ronco C, Cruz D. Hemodiafiltration history, technology, and clinical results. Adv Chronic Kidney Dis 2007; 14: 231-243
13. Ledebo I, Blankestijn PJ. Haemodiafiltration-optimal efficiency and safety. NDT Plus 2010; 3: 8-16
14. Carracedo J, Merino A, Nogueras S et al. On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: A prospective, crossover study. J Am Soc Nephrol 2006; 17: 2315-2321
15. Filiopoulos V, Hadjiyannakos D, Metaxaki P et al. Inflammation and oxidative stress in patients on hemodiafiltration. Am J Nephrol 2008; 28: 949-957
16. Morena M, Cristol JP, Bosc JY et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: A contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 422-427
17. Kalousová M, Kielstein JT, Hodková M et al. No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif 2006; 24: 439-444
18. Grooteman MP, Van den Dorpel MA, Bots ML et al. CONTRAST Investigators. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012; 23: 1087-1096
19. Ok E, Asci G, Toz H et al. Turkish Online Haemodiafiltration Study. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: Results from the Turkish OL-HDF study. Nephrol Dial Transplant 2013; 28: 192-202
20. Maduell F, Moreso F, Pons M et al. For the ESHOL study group: High-efficiency postdilution on-line hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013; 24: 487-497
21. Blankestijn PJ. Has the time now come to more widely accept hemodiafiltration in the United States?. J Am Soc Nephrol 2013; 24: 332-334
22. Fathi R, Haluska B, Isbel N et al. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004; 43: 616-623
23. Blacher J, Pannier B, Guerin AP et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570-574
24. Meinders JM, Brands PJ, Willigers JM et al. Assessment of the spatial homogeneity of artery dimension parameters with high frame rate 2-D Bmode. Ultrasound Med Biol 2001; 27: 785-794
25. Beaussier H, Naggara O, Calvet D et al. Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging. JACC Cardiovasc Imaging 2011; 4: 468-477
26. Joannides R, Haefeli WE, Linder L et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-1319
27. Lieberman EH, Gerhard MD, Uehata A et al. Flow-induced vasodilation of the human brachial artery is impaired in patients 40 years of age with coronary artery disease. Am J Cardiol 1996; 78: 1210-1214
28. Maltete D, Bellien J, Cabrejo L et al. Hypertrophic remodeling and increased arterial stiffness in patients with intracranial aneurysms. Atherosclerosis 2010; 211: 486-491
29. Joannidès R, Monteil C, de Ligny BH et al. Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant 2011; 11: 2414-2422
30. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234: 279-293
31. Macías Núñez JF, Ghais Z, Bustamante J et al. Evaluation of oxidant-Antioxidant balance in patients on maintenance haemodialysis: A comparative study of dialyzers membranes. Nephron Clin Pract 2010; 114: C67-c73
32. Bellien J, Iacob M, Remy-Jouet I et al. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension. Circulation 2012; 125: 1266-1275
33. Chai V, Vassilakos A, Lee Y et al. Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples. J Clin Lab Anal 2005; 19: 182-188
34. Peng A, Wu T, Zeng C et al. Adverse effects of simulated hyper-And hypophosphatemia on endothelial cell function and viability. PLoS One 2011; 6: E23268
35. Banquet S, Gomez E, Nicol L et al. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 2011; 124: 1059-1069
36. Gomez E, Vercauteren M, Kurtz B et al. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B. J Mol Cell Cardiol 2012; 52: 1257-1264
37. Boutouyrie P, Bussy C, Lacolley P et al. Association between local pulse pressure, mean blood pressure, and large-Artery remodeling. Circulation 1999; 100: 1387-1393
38. Ward RA, Schmidt B, Hullin J et al. A comparison of on-line hemodiafiltration and high-flux hemodialysis: A prospective clinical study. J Am Soc Nephrol 2000; 11: 2344-2350
39. Meert N, Waterloos MA, Van Landschoot M et al. Prospective evaluation of the change of predialysis protein-bound uremic solute concentration with postdilution online hemodiafiltration. Artif Organs 2010; 34: 580-585
40. Jourde-Chiche N, Dou L, Sabatier F et al. Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients. J Thromb Haemost 2009; 7: 1576-1584
41. LornoyW, De Meester J, Becaus I et al. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 2006; 16: 47-53
42. Oates T, Pinney JH, Davenport A. Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin response. Am J Nephrol 2011; 33: 70-75
43. Chiasson VL, Quinn MA, Young KJ et al. Protein kinase CbetaII-mediated phosphorylation of endothelial nitric oxide synthase threonine 495 mediates the endothelial dysfunction induced by FK506 (tacrolimus). J Pharmacol Exp Ther 2011; 337: 718-723
44. Badiou S, Cristol JP, Jaussent I et al. Fine-Tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination. Clin J Am Soc Nephrol 2008; 3: 423-430